However, in a mouse model of hepatocellular carcinoma, SOCS1 deficiency is associated with increased expression of a p53 target gene, the cyclin-dependent kinase inhibitor p21CIP1/WAF1 (p21) [23]. This evidence concerns the gene SOCS1 and hepatocellular carcinoma.